Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2021

The importance of maternal insulin resistance throughout
pregnancy on neonatal adiposity
Rodrigo A. Lima
Universitat Graz

Gernot Desoye
Medizinische Universität Graz

David Simmons
Western Sydney University

Roland Devlieger
KU Leuven– University Hospital Leuven

Sander Galjaard
KU Leuven– University Hospital Leuven

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Lima, Rodrigo A.; Desoye, Gernot; Simmons, David; Devlieger, Roland; Galjaard, Sander; Corcoy, Rosa;
Adelantado, Juan M.; and Dunne, Fidelma, "The importance of maternal insulin resistance throughout
pregnancy on neonatal adiposity" (2021). Paediatrics Publications. 2627.
https://ir.lib.uwo.ca/paedpub/2627

Authors
Rodrigo A. Lima, Gernot Desoye, David Simmons, Roland Devlieger, Sander Galjaard, Rosa Corcoy, Juan M.
Adelantado, and Fidelma Dunne

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/2627

Received: 18 January 2020

|

Revised: 21 March 2020

|

Accepted: 24 March 2020

DOI: 10.1111/ppe.12682

ORIGINAL ARTICLE

The importance of maternal insulin resistance throughout
pregnancy on neonatal adiposity
Rodrigo A. Lima1
| Gernot Desoye2 | David Simmons3,4 | Roland Devlieger5 |
Sander Galjaard5,6 | Rosa Corcoy7,8 | Juan M. Adelantado7,8 | Fidelma Dunne9 |
Jürgen Harreiter10 | Alexandra Kautzky-Willer10 | Peter Damm11 |
Elisabeth R. Mathiesen11 | Dorte M. Jensen12,13 | Lise-Lotte T. Andersen12,14 |
Mette Tanvig12,14 | Annunziata Lapolla15 | Maria G. Dalfra15 | Alessandra Bertolotto16 |
Urszula Manta17 | Ewa Wender-Ozegowska17 | Agnieszka Zawiejska17 | David J. Hill18 |
Frank J. Snoek19 | Judith G. M. Jelsma20 | Mireille van Poppel1
1

Institution of Sport Science, University of Graz, Graz, Austria

2

Department of Obstetrics and Gynecology, Medizinische Universitaet Graz, Graz, Austria

3

Western Sydney University, Campbelltown, New South Wales, Australia

4

The Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK

5

KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology and Obstetrics, University Hospitals Leuven, Leuven,
Belgium
6

Division of Obstetrics and Prenatal Medicine, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam,
The Netherlands

7

Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

8

CIBER Bioengineering, Biomaterials and Nanotechnology, Instituto de Salud Carlos III, Zaragoza, Spain

9

Galway Diabetes Research Centre and College of Medicine Nursing and Health Sciences, National University of Ireland, Galway, Ireland

10

Gender Medicine Unit, Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

11

Departments of Endocrinology and Obstetrics, Faculty of Health and Medical Sciences, Center for Pregnant Women with Diabetes, Rigshospitalet, Institute
of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

12

Department of Gynecology and Obstetrics, Odense University Hospital, University of Southern Denmark, Odense, Denmark

13

Department of Clinical Research, Faculty of Health Sciences, Steno Diabetes Center Odense, Odense University Hospital, University of Southern Denmark,
Odense, Denmark

14

Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

15

Universita Degli Studi di Padova, Padua, Italy

16

Azienda Ospedaliero Universitaria – Pisa, Pisa, Italy

17

Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland

18

Recherche en Santé Lawson SA, Bronschhofen, Switzerland

19

Department of Medical Psychology, Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The
Netherlands

20

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam,
The Netherlands

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd
Paediatr Perinat Epidemiol. 2021;35:83–91.		wileyonlinelibrary.com/journal/ppe

|

83

84

|

LIMA et al.

Correspondence
Rodrigo A. Lima, Institute of Sport Science,
University of Graz, Graz, Austria.
Email: rodrigoantlima@gmail.com
Funding information
This study was funded by the European
Union 7th Framework (FP7/ 2007–2013)
under Grant Agreement no. 242187.
Additional funding was provided by the
Netherlands Organisation for Health
Research and Development (ZonMw)
(grant 200310013), in the Netherlands. In
Poland, additional funding was obtained
from Polish Ministry of Science (grants
2203/7, PR/2011/2). In Denmark,
additional funding was provided by Odense
University Free Research Fund. In Spain,
additional funding was provided by CAIBER
1527-B-226. The study sponsors were not
involved in the design of the study; the
collection, analysis, and interpretation of
data; writing the report; or the decision to
submit the report for publication.

Abstract
Background: Although previous studies evaluated the association of maternal health
parameters with neonatal adiposity, little is known regarding the complexity of the
relationships among different maternal health parameters throughout pregnancy and
its impact on neonatal adiposity.
Objectives: To evaluate the direct and indirect associations between maternal insulin
resistance during pregnancy, in women with obesity, and neonatal adiposity. In addition, associations between maternal fasting glucose, triglycerides (TG), non-esterified
fatty acids (NEFA), and neonatal adiposity were also assessed.
Methods: This is a longitudinal, secondary analysis of the DALI study, an international project conducted in nine European countries with pregnant women with
obesity. Maternal insulin resistance (HOMA-IR), fasting glucose, TG, and NEFA were
measured three times during pregnancy (<20, 24-28, and 35-37 weeks of gestation).
Offspring neonatal adiposity was estimated by the sum of four skinfolds. Structural
equation modelling was conducted to evaluate the direct and indirect relationships
among the variables of interest.
Results: Data on 657 mother-infant pairs (50.7% boys) were analysed. Neonatal boys
exhibited lower mean sum of skinfolds compared to girls (20.3 mm, 95% CI 19.7, 21.0
vs 21.5 mm, 95% CI 20.8, 22.2). In boys, maternal HOMA-IR at <20 weeks was directly associated with neonatal adiposity (β = 0.35 mm, 95% CI 0.01, 0.70). In girls,
maternal HOMA-IR at 24-28 weeks was only indirectly associated with neonatal
adiposity, which implies that this association was mediated via maternal HOMA-IR,
glucose, triglycerides, and NEFA during pregnancy (β = 0.26 mm, 95% CI 0.08, 0.44).
Conclusions: The timing of the role of maternal insulin resistance on neonatal adiposity depends on fetal sex. Although the association was time-dependent, maternal
insulin resistance was associated with neonatal adiposity in both sexes.
KEYWORDS

endocrinology, gynaecology, insulin, lipid metabolism, obesity

1 | BAC KG RO U N D

neonatal adiposity, some aspects still require further evaluation.
First, it is crucial that the entire pregnancy period is taken into ac-

Maternal obesity is associated with neonatal1-4 and childhood adi-

count. Fetal development depends on the maternal metabolic profile

posity, and childhood obesity2,5 is not only associated with a higher

throughout the whole pregnancy period,6-13 illustrated by the fact

chance of obesity, but also premature death and disability in adult-

that obese women or women who develop gestational diabetes have

5

hood. While maternal insulin resistance and fasting glucose have a
positive association with neonatal adiposity,

6-13

larger fetuses already by 20 weeks of gestation.14,15 Second, there

the role of maternal

is evidence that neonatal girls might be more insulin resistant than

triglycerides and non-esterified fatty acids on neonatal adiposity

boys,16,17 and mechanisms underlying the relationship between ma-

remains controversial.6-8,11 It is unclear whether such associations

ternal metabolism and neonatal adiposity might differ depending on

are causal, in the causal pathway or a consequence of the metabolic

the neonatal sex.18

pathways involved.

The aim of this investigation was to evaluate the direct and in-

Shapiro et al6 reported that HOMA-IR, glucose, but not tri-

direct associations between insulin resistance during pregnancy

glycerides and non-esterified fatty acids at 24-32 weeks of gesta-

and neonatal adiposity, as measured by sum of skinfolds. In addi-

tion mediated the association between maternal pre-pregnancy

tion, the direct and indirect associations between fasting glucose,

body mass index (BMI) and neonatal adiposity. Although this study6

triglycerides, non-esterified fatty acids, and neonatal adiposity

provided relevant insights regarding the possible underlying mech-

were also assessed. This is a novel approach because it assesses

anisms in the relationship between maternal metabolic profile and

the complexity of the relationships among different maternal health

|
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parameters throughout pregnancy and its impact on neonatal adiposity. Although the observational design does not allow to assert
on causality, it is a valuable approach for generating hypothesis to
be tested in clinical trials.

Synopsis
Study question
How is the synergic relationship of maternal insulin re-

2 | M E TH O DS

sistance, fasting glucose, triglycerides, and non-esterified

2.1 | Design and participants

with obesity?

fatty acids with neonatal adiposity in pregnant women

This is a longitudinal, secondary analysis of the DALI study

What's already known

which was a multicentre parallel randomised trial conducted in

Maternal insulin resistance and fasting glucose have a

nine European countries (Austria, Belgium, Denmark, Ireland,

positive association with neonatal adiposity, and the role

Italy, Netherlands, Poland, Spain, and United Kingdom) during

of maternal triglycerides and non-esterified fatty acids on

2012-2015. Pregnant women with a pre-pregnancy body mass

neonatal adiposity remains controversial.

index (BMI) of ≥29 kg/m 2 , before 20 weeks of gestation, with
a singleton pregnancy, and aged ≥18 years were invited to participate.

19

What this study adds

Exclusions included diagnosis with early gestational

The association between maternal insulin resistance and

diabetes mellitus (GDM), pre-existing diabetes, and chronic

neonatal adiposity differed depending on the infant sex.

medical conditions. The study was prospectively registered

While adiposity in boys was associated directly with ma-

as a randomised controlled trial (RCT) on 21 November 2011

ternal insulin resistance in the beginning of pregnancy,

(ISRCTN70595832).

adiposity in girls was associated with maternal insulin resistance at 24-28 weeks of gestation via a chain of relation-

2.2 | Randomisation, masking, and interventions

ships through fasting glucose, triglycerides, and free fatty
acids.

Using a computerised random number generator, women were randomised to one of the following groups, pre-stratified for site: (a) healthy
eating; (b) physical activity; (c) healthy eating + physical activity; (d)

baseline (<20 weeks), 24-28 weeks, and at 35-37 weeks of gestation.

healthy eating + physical activity + vitamin D; (e) healthy eating + physi-

Body mass index (BMI) was calculated as weight in kg divided by the

cal activity + placebo; (f) vitamin D; (g) placebo; and (h) control. Staff

square of height in metres.

involved with measurements, but not participants, were blinded to the

After fasting for 10 hours, blood was collected in three different

intervention. Since methodology has been extensively described else-

periods during pregnancy (<20, 24-28, and 35-37 weeks of gestation).

where,19 only variables of interest will be detailed in this manuscript.

The procedures were identical in all pregnancy periods. All the samples were centrifuged and separated aliquots (1000 or 250 μL) placed

2.3 | Measurements
2.3.1 | Neonatal adiposity

in microrack tubes and stored at −20 or −80°C in the central trial laboratory, prior to analysis, in Graz, Austria. The maternal plasma concentrations of fasting glucose, triglycerides, and non-esterified fatty acids
were quantified. For insulin and leptin, commercially available enzyme-linked immunosorbent assays (ELISAs) were used. Insulin resis-

Triceps, subscapular, supra-iliac, and quadriceps skinfolds were meas-

tance was derived from homeostasis model assessment (HOMA-IR).20

ured with a Harpenden skinfold calliper, and values summed. Each
skinfold measurement was repeated once, and if a difference of more
than 0.2 mm was registered, a third measurement was performed and

2.3.3 | Covariates

the average of the three was taken. Time between birth and measurements was registered in hours—neonatal age at the measurement.

Information on possible covariates was collected in the baseline
questionnaire or from medical files: intervention groups, maternal

2.3.2 | Maternal measurements

age, gestational age during pregnancy (<20, 24-28 and 35-37 weeks),
maternal ethnicity (European descent and non-European descent),
maternal education (low [<high school], medium [completed high

Maternal height was determined at baseline with a stadiometer

school] and high [higher education]), smoking status at 35-37 weeks

(SECA 206; SECA, Birmingham United Kingdom). Women were

of gestation (yes and no), gestational age at birth (weeks of gesta-

weighed on calibrated electronic scales (SECA 888 and 877) at

tion), and neonatal age (hours).
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3.1 | Maternal insulin resistance in relation to
neonatal adiposity

Prevalence, means, standard deviations (SD), medians, and interquartile ranges (IQR) were used to describe the sample. Descriptive

In boys, maternal HOMA-IR at <20 weeks of gestation was directly

mean differences are presented with respective 95% confidence

associated with neonatal sum of skinfolds (β = 0.35 mm, 95% CI 0.01,

intervals.

0.70). No other associations of maternal HOMA-IR with neonatal

Structural equation modelling was performed to evaluate the

sum of skinfolds in boys were found (see Table 3). In girls, maternal

direct and indirect associations among maternal HOMA index, glu-

HOMA-IR was not directly associated with neonatal sum of skin-

cose, triglycerides, non-esterified fatty acids, and neonatal sum of

folds at any time during pregnancy. However, maternal HOMA-IR

skinfolds. Direct association refers to the association between two

at 24-28 weeks of gestation was indirectly associated with neonatal

variables, whereas indirect association refers to the association be-

sum of skinfolds (β = 0.26 mm, 95% CI 0.08, 0.44).

tween two variables that is mediated via a third variable. All the stan-

Figure 1 illustrates the indirect association of maternal HOMA-IR

dard errors in the analyses were adjusted for the cluster structure

at 24-28 weeks of gestation with neonatal sum of skinfolds only in

of the data (individuals nested within site of recruitment). Table 1

girls because we did not observe an indirect association between

describes the role of each variable in the diagram in detail, including

maternal HOMA-IR and neonatal sum of skinfolds in boys. Note that

the variables of interest and the adjustments. We have more than

not all the arrows were drawn for clarity. We only drew the most

80% statistical power to detect associations with small effect sizes

relevant arrows related to the primary and secondary outcomes of

2

(f = 0.06) considering the number of neonatal boys (n = 333) and

the present study. For more details regarding all the relationships

girls (n = 324) evaluated, accounting for the number of exposures

tested in our diagram, see Table 1. The indirect association of ma-

and confounding variables in our analysis. All analyses were per-

ternal HOMA-IR at 24-28 weeks of gestation with neonatal sum of

formed in STATA version 15 for windows (StataCorp LP).

skinfolds indicates that a higher maternal HOMA-IR at 24-28 weeks
initiates a chain of relationships through maternal fasting glucose,

2.5 | Missing data

triglycerides, and NEFA at 24-28 weeks and HOMA-IR, fasting glucose, triglycerides, and NEFA at 35-37 weeks that culminates in a
higher neonatal sum of skinfolds (Figure 1). The overall indirect as-

We used the maximum likelihood for missing values method, which

sociation between maternal HOMA-IR at 24-28 weeks and neonatal

does not exclude a participant in the analysis because of a missing

sum of skinfolds was 0.26 mm (95% CI 0.06, 0.36), and the indirect

value in one of the variables. Thus, we avoided selection bias in our

association between maternal HOMA-IR at 24-28 weeks and neona-

analysis.21 Therefore, all the 657 neonates and their mothers in the

tal sum of skinfolds only via maternal fasting glucose at 24-28 weeks

study were included in the main analysis.

was 0.21 mm (95% CI 0.06, 0.36), indicating that 81.0% of the indirect relationship between maternal HOMA-IR at 24-28 weeks

2.6 | Ethics approval
We obtained the local ethics committee approvals in all the nine

and neonatal sum of skinfolds was mediated via fasting glucose at
24-28 weeks.

formed consent of all women was acquired.

3.2 | Maternal fasting glucose,
triglycerides, and non-esterified fatty acids in relation
to neonatal adiposity

3 | R E S U LT S

In boys, maternal triglycerides at <20 weeks were indirectly

countries, in which the study was conducted. Moreover, written in-

and negatively associated with neonatal sum of skinfolds
In total, 657 neonates (50.7% boys) and their mothers with obe-

(β = −0.49 mm, 95% CI −0.97, −0.01). Moreover, triglycerides at

sity were included in the study. On average, the mothers were 32.0

24-28 weeks of gestation were directly and negatively associ-

(±5.4) years of age. Median gestational age at delivery was 39.7 (IQR:

ated with neonatal sum of skinfolds (β = −1.39 mm, 95% CI −2.58,

38.7; 40.9) weeks of gestation. Most mothers perceived themselves

−0.21). Maternal fasting glucose and NEFA were not associated

as European descent (86.4%). Among the mothers, 55.9% reported a

with neonatal sum of skinfolds in boys at any time during preg-

high educational level and 31.8% a medium educational level. Median

nancy (Table 4).

neonatal age at measurement was 5.0 (IQR: 2.0; 24.0) hours after

In girls, maternal fasting glucose at <20 weeks was inversely and

birth. Boys exhibited a lower sum of skinfolds (mean sum of skinfolds

directly associated with neonatal sum of skinfolds (β = −2.52 mm,

20.3 mm, 95% CI 19.7, 21.0) compared to girls (mean sum of skinfolds

95% CI −4.86, −0.19), whereas the indirect association was posi-

21.5 mm, 95% CI 20.8, 22.2). Table 2 presents descriptive data on the

tive (β = 1.82 mm, 95% CI 0.85, 2.79). Thus, the total association

mothers’ metabolic variables at <20 weeks of gestation according to

between maternal fasting glucose at <20 weeks and neonatal sum

the sex of the fetus.

of skinfolds was not significant (β = −0.70 95% CI −2.94, 1.54).

|
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Pathways between all the variables in the analysis
Outcomes

Exposures
HOMA-IR at 13-20 wk

HOMA-Index at 24-28 and 35-37 wk; Glucose at 13-20, 24-28 and 35-37 wk; Triglycerides
at 13-20, 24-28 and 35-37 wk; Non-esterified fatty acids at 13-20, 24-28 and 35-37 wk;
Neonatal fatness

HOMA-IR at 24-28 wk

HOMA-Index at 35-37 wk; Glucose at 24-28 and 35-37 wk; Triglycerides at 24-28 and
35-37 wk; Non-esterified fatty acids at 24-28 and 35-37 wk; Neonatal fatness

HOMA-IR at 35-37 wk

Glucose at 35-37 wk; Triglycerides at 35-37 wk; Non-esterified fatty acids at 35-37 wk;
Neonatal fatness

Fasting glucose at 13-20 wk

Glucose at 24-28 and 35-37 wk; Neonatal fatness

Fasting glucose at 24-28 wk

Glucose at 35-37 wk; Neonatal fatness

Fasting glucose at 35-37 wk

Neonatal fatness

Triglycerides at 13-20 wk

Triglycerides at 24-28, 35-37 wk; Neonatal fatness

Triglycerides at 24-28 wk

Triglycerides at 35-37 wk; Neonatal fatness

Triglycerides at 35-37 wk

Neonatal fatness

Non-esterified fatty acids at 13-20 wk

Non-esterified fatty acids at 24-28, 35-37 wk; Neonatal fatness

Non-esterified fatty acids at 24-28 wk

Non-esterified fatty acids at 35-37 wk; Neonatal fatness

Non-esterified fatty acids at 35-37 wk

Neonatal fatness

Confounders
Intervention groups

BMI at 13-20, 24-28 and 35-37 wk;

Gestational age

HOMA-Index at 13-20, 24-28 and 35-37 wk;

Maternal ethnicity

Glucose at 13-20, 24-28 and 35-37 wk;

Maternal education

Triglycerides at 13-20, 24-28 and 35-37 wk;

Maternal age

Non-esterified fatty acids at 13-20, 24-28 and 35-37 wk;

Smoking status

Neonatal fatness

BMI at 13-20 wk

BMI at 24-28 and 35-37 wk;
HOMA-Index at 13-20, 24-28 and 35-37 wk;
Glucose at 13-20, 24-28 and 35-37 wk;
Triglycerides at 13-20, 24-28 and 35-37 wk;
Non-esterified fatty acids at 13-20, 24-28 and 35-37 wk;
Neonatal fatness

BMI at 24-28 wk

BMI at 35-37 wk;
HOMA-Index at 24-28 and 35-37 wk;
Glucose at 24-28 and 35-37 wk;
Triglycerides at 24-28 and 35-37 wk;
Non-esterified fatty acids at 24-28 and 35-37 wk;
Neonatal fatness

BMI at 35-37 wk

HOMA-Index at 35-37 wk;
Glucose at 35-37 wk;
Triglycerides at 35-37 wk;
Non-esterified fatty acids at 35-37 wk;
Neonatal fatness

Neonatal age

Neonatal fatness

Gestational age at birth

Maternal fasting glucose at 24-28 weeks was directly and positively associated with neonatal sum of skinfolds (β = 2.51 mm, 95%
CI 0.80, 4.23). Maternal NEFA at 35-37 weeks were directly and

3.3 | Comment
3.3.1 | Principal findings

negatively associated with neonatal sum of skinfolds (β=−3.26 mm,
95% CI −5.91, −0.61). Maternal triglycerides were not associated

The primary aim of this investigation was to evaluate the potential

with neonatal sum of skinfolds in girls at any time during pregnancy

pathophysiological pathways underlying the association of mater-

(Table 4).

nal insulin resistance with neonatal adiposity in pregnant women
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<20 wk of gestation
Boys
Maternal variables

n

HOMA-IR ([µU/
mL]*[mmol/L])

327

Fasting Glucose
(mmol/L)

Girls
n

Mean (95% CI)

3.0 (2.7, 3.4)

315

3.3 (2.9, 3.6)

331

4.6 (4.6, 4.6)

320

4.6 (4.6, 4.7)

Triglycerides (mmol/L)

320

1.3 (1.3, 1.4)

307

1.4 (1.3, 1.4)

Non-esterified fatty
acids (mmol/L)

320

0.6 (0.6, 0.7)

307

0.64 (0.6, 0.7)

BMI (kg/m2)

333

324

34.5 (34.0, 35.0)

Exposures

Neonatal
sex

Mean (95% CI)

34.4 (34.0, 34.8)

Neonatal sum of skinfolds (mm)
Direct association

Indirect association

TA B L E 3 Path coefficients of the diTotal association

HOMA-IR
at < 20 wk

Boys

0.35 (0.01, 0.70)

−0.02 (−0.17, 0.14)

0.34 (0.01, 0.66)

Girls

0.20 (−0.02, 0.43)

−0.05 (−0.18, 0.08)

0.15 (−0.08, 0.38)

HOMA-IR at
24-28 wk

Boys

−0.43 (−0.88, 0.03)

0.09 (−0.05, 0.22)

−0.34 (−0.83, 0.15)

HOMA-IR at
35-37 wk

TA B L E 2 Mean and 95% confidence
intervals of the mothers’ anthropometric
and metabolic variables at <20 wk of
gestation according to the sex of the fetus

Girls

0.01 (−0.41, 0.41)

0.26 (0.08, 0.44)

0.26 (−0.09, 0.61)

Boys

0.05 (−0.12, 0.22)

0.05 (−0.03, 0.14)

0.10 (−0.11, 0.31)

Girls

−0.01 (−0.12, 0.10)

0.07 (−0.01, 0.15)

0.06 (−0.05, 0.17)

rect, indirect, and total association between maternal HOMA-IR and neonatal
sum of skinfolds

Note: Indirect association refers to the association between the exposure (maternal HOMA-IR at different periods during pregnancy) and the outcome (neonatal sum of skinfolds) which is mediated by all
the variables in the pathway (see Table 1 for detailed description).

with obesity. Since this is a longitudinal study, it is not possible to

our results. However, the analyses were adjusted for the in-

infer causality in our conclusions. Our results showed that the asso-

tervention component. Another limitation is the lack of nor-

ciation between maternal insulin resistance and neonatal adiposity

mal or overweight women in the study; thus, we can only

differed depending on the infant sex. While adiposity in boys was

generalise our findings to Caucasian obese women. However,

associated directly with maternal insulin resistance in the beginning

the prevalence and the increasing rate of obesity in women

of pregnancy, adiposity in girls was associated with maternal insulin

in reproductive age are alarming and so the complication re-

resistance at 24-28 weeks of gestation via a chain of relationships

lated to obesity during pregnancy. 22,23 Furthermore, more

through fasting glucose, triglycerides, and free fatty acids.

direct measures of neonatal adiposity would have been preferred, such as from air displacement plethysmography, al-

3.3.2 | Strengths of the study
Strengths of our study are that we have measures of maternal metabolic parameters at three time points in pregnancy, enabling us to look

though sum of skinfolds provide valid estimates of adiposity
in neonates. 24,25

3.3.4 | Interpretation

at longitudinal associations. Data were collected in nine European
countries, increasing the external validity of our findings. Importantly,

Regarding the pathophysiological pathways on the relationship

the mechanistic path analysis adds substantial insights on how some

between maternal metabolism and neonatal adiposity, Shapiro

of the metabolic parameters during pregnancy in women with obesity

et al7 observed that 21.0% of the association between mater-

could affect neonatal adiposity, although we cannot assert on causal-

nal pre-pregnancy BMI and neonatal adiposity was mediated by

ity and our model should be tested in clinical trials.

HOMA-IR and fasting glucose levels, but not by triglycerides or
non-esterified fatty acids.7 This is partly in line with our results, al-

3.3.3 | Limitations of the data

though Shapiro et al7 included pregnant women with and without
obesity whereas we only included pregnant women with obesity.
We observed that fasting glucose mediated 81.0% of the associa-

Our findings should be interpreted with caution, since women

tion between maternal HOMA-IR and neonatal adiposity, but only

were exposed to different interventions that could influence

in girls.
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F I G U R E 1 Paths in the association
between maternal HOMA-IR at 2428 wk and neonatal sum of skinfolds
in girls. Fasting glucose, triglycerides,
and non-esterified fatty acids (NEFA) at
24-28 wk were directly associated with
fasting glucose, triglycerides, and NEFA at
35-37 wk, respectively. SSF refers to the
neonatal sum of skinfolds (mm). Solid lines
refer to direct relationships; dashed lines
refer to indirect relationships

TA B L E 4 Path coefficients of the direct, indirect, and total association between maternal fasting glucose, triglycerides, non-esterified
fatty acids, and neonatal sum of skinfolds
Outcome: Sum of skinfolds (mm)
Boys

Exposures, in mmol/l

Gestational age during
pregnancy

Fasting glucose

<20 wk

Triglycerides

Non-esterified fatty acids

Total association

Direct association

Indirect association

β (95% CI)

β (95% CI)

β (95% CI)

0.44 (−1.10, 1.98)

−0.31 (−2.06, 1.43)

0.75 (−0.60, 2.11)
0.59 (−0.38, 1.57)

24-28 wk

0.68 (−1.36, 2.72)

0.09 (−1.86, 2.04)

35-37 wk

1.22 (−0.75, 3.19)

1.22 (−0.75, 3.19)

<20 wk

1.12 (−0.59, 2.84)

1.61 (−0.31, 3.54)

24-28 wk

−0.87 (−1.58, −0.15)

−1.39 (−2.58, −0.21)

−0.49 (−0.97, −0.01)

35-37 wk

0.78 (−0.26, 1.81)

0.78 (−0.26, 1.81)

<20 wk

1.01(−1.27, 3.28)

1.19 (−0.33, 2.71)

−0.18 (−1.92, 1.55)

24-28 wk

−1.58 (−5.90, 2.75)

−1.77 (−6.17, 2.62)

0.20 (−0.38, 0.77)

35-37 wk

1.32 (−2.56, 5.20)

1.32 (−2.56, 5.20)

0.53 (−0.23, 1.28)

Outcome: Sum of skinfolds (mm)
Girls
Total association

Direct association

Indirect association

β (95% CI)

β (95% CI)

β (95% CI)

Exposures, in mmol/l

Gestational age during
pregnancy

Fasting glucose

<20 wk

−0.70 (−2.94, 1.54)

−2.52 (−4.86, −0.19)

1.82 (0.85, 2.79)

24-28 wk

2.84 (1.38, 4.30)

2.51 (0.80, 4.23)

0.33 (−0.24, 0.90)

35-37 wk

0.71 (−0.49, 1.91)

0.71 (−0.49, 1.91)

<20 wk

0.80 (−0.30, 1.90)

0.43 (−1.31, 2.17)

0.37 (−0.99, 1.72)

24-28 wk

0.01 (−1.47, 1.50)

−0.64 (−2.46, 1.19)

0.65 (−0.44, 1.74)

35-37 wk

0.93 (−0.63, 2.49)

0.93 (−0.63, 2.49)

<20 wk

1.73 (−0.88, 4.34)

1.47 (−0.38, 3.31)

0.26 (−1.07, 1.60)

24-28 wk

2.23 (−1.92, 6.38)

3.02 (−0.99, 7.03)

−0.79 (−1.74, 0.16)

35-37 wk

−3.26 (−5.91, −0.61)

−3.26 (−5.91, −0.61)

Triglycerides

Non-esterified fatty acids

Note: Indirect association refers to the association between the exposure and the outcome (neonatal sum of skinfolds) which is mediated by all the
variables in the pathway (see Table 1 for detailed description). The empty cells on the indirect relationships between fasting glucose, triglycerides,
non-esterified fatty acids at 35-37 wk of gestation and neonatal sum of skinfolds are due to the lack of possible indirect relationships to be estimated
(there are no intermediate variable between these exposures and the outcome).
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The direct association between maternal glucose and neona6,8-10

period for neonatal outcomes in boys and in the middle of pregnancy

Results from

for girls. Although our model explained most of the pathophysiolog-

the Healthy Heart Study6,7 and the Hyperglycemia and Adverse

ical pathways from insulin resistance to neonatal adiposity in girls,

Pregnancy Outcome (HAPO) study26 demonstrated the importance

the pathways in boys were still uncertain. A next step would be to

of maternal glucose levels for neonatal adiposity. In our sample only

investigate the associations of maternal metabolism with cord blood

including pregnant women with obesity, we did not observe any re-

parameters, to confirm the Pedersen-Freinkel hypothesis that ma-

lationship between maternal fasting glucose and neonatal adiposity

ternal glucose and lipids increase fetal insulin levels and thereby in-

in boys. In girls, maternal fasting glucose at 24-28 weeks was associ-

crease fetal fat accretion.35

tal adiposity is well established in the literature.

ated with neonatal adiposity. No relationship was observed between
maternal fasting glucose at <20 weeks or at 35-37 weeks and neonatal adiposity. We encourage future investigations to evaluate this

4 | CO N C LU S I O N S

matter in more depth, with assessment of maternal glucose levels at
multiple time points during pregnancy.

Maternal insulin resistance in women with obesity was associ-

The importance of triglycerides and non-esterified fatty acids

ated with adiposity in neonates. More specifically, higher insulin

levels during pregnancy on neonatal adiposity is not well estab-

resistance in the beginning of pregnancy was related to higher

lished.6,8,11 When associations are found they are usually posi-

adiposity in boys, whereas this association in girls was observed

tive. 27 In our sample with pregnant women with obesity, maternal

with insulin resistance in the middle of the pregnancy period.

triglycerides were negatively associated with neonatal adiposity in

Obstetricians, midwives, and health professionals should be

boys at <20 weeks (indirectly) and at 24-28 weeks (directly). In girls,

aware of the deleterious impact of maternal insulin resistance on

maternal non-esterified fatty acids at 35-37 weeks showed a nega-

the offspring health and support pregnant women with life style

tive association with neonatal adiposity. Pregnant women with obe-

changes (nutrition and physical activity) which could lower insulin

sity from DALI exposed to motivational sessions on healthy eating

resistance during pregnancy and consecutively benefit neonatal

presented higher levels of NEFA, and higher levels of NEFA were

body composition. 36

also found in the cord blood of the offspring when compared to controls. 28 In addition, maternal diet has been shown to influence tri-

AC K N OW L E D G E M E N T S
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Whether this influenced the association between lipids and neonatal

in this study. In the United Kingdom, the DALI team acknowledge

adiposity is unknown. However, there seems to be a complex inter-

the support received from the NIHR Clinical Research Network:

action between maternal glycaemia and lipids in their influence on
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fetal growth, since maternal lipids were only associated with fetal
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glyceride and free fatty acid levels, even after a period of fasting.

growth in women with hyperglycaemia but not in those with normal
glycaemia.30 Whether this is due to differences in insulin resistance
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Sex differences in the associations between maternal metabolism and neonatal adiposity have been reported previously, but are
inconsistent.16,17,31 Inconsistencies might be due to study population (ie women with obesity versus with normal weight, with normal
glycaemia versus with hyperglycaemia) or due to differences in the
timing in pregnancy. Theoretically, male and female fetuses seem
to experience different growth strategies in utero.32,33 It is not well
established yet, but male embryos tend to have more rapid cell divisions compared to females,34 generating a more rapid growth.32,33
This higher growth rate might explain the higher response to
changes in nutrient supply reported in male fetuses.32,33 These different growth strategies might result in differences in nutritional
needs, at different times in pregnancy and our findings support this
concept. However, more systematic assessment of sex differences
in the relationship of maternal metabolic parameters with neonatal
adiposity is needed.
We evaluated the pathophysiological pathway from maternal insulin resistance, through maternal glucose, triglycerides, and
non-esterified fatty acids to neonatal adiposity in pregnant women
with obesity. It indicates again the relevance of the early pregnancy
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